Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended December 31, 2004
 
 
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From _____ to _____

COMMISSION FILE NUMBER 0-24765

hi/fn, inc.
(Exact Name of Registrant as specified in its Charter)

Delaware 33-0732700
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)

750 University Avenue, Los Gatos, California 95032
(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code: (408) 399-3500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES  þ NO  ¨

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

YES  þ NO  ¨

The number of shares outstanding of the Registrant’s Common Stock, par value $.001 per share, was 13,988,201 at February 8, 2005.


TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Cash Flows
Notes to Condensed Consolidated Financial Statements
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosure About Market Risks
Item 4. Controls and Procedures
PART II. OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K
Signatures
Index to Exhibits
Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2

Table of Contents

HIFN, INC.

INDEX TO FORM 10-Q

PART I. FINANCIAL INFORMATION
  Item 1. Financial Statements (unaudited)
Condensed Consolidated Balance Sheets as of December 31, 2004 and September 30, 2004 3
Condensed Consolidated Statements of Operations for the three months ended December 31, 2004 and 2003 4
Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2004 and 2003 5
Notes to Condensed Consolidated Financial Statements 6 - 9
  Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 10 - 27
  Item 3. Quantitative and Qualitative Disclosure About Market Risks 27
  Item 4. Controls and Procedures 27 - 28
Part II. OTHER INFORMATION 29
  Item 6. Exhibits and Reports on From 8-K 29
Signatures 30
Index to Exhibits

-2-


Table of Contents

   PART 1 – FINANCIAL INFORMATION

   Item 1. Financial Statements

HIFN, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)
(unaudited)

December 31,
2004

September 30,
2004

           
ASSETS
   CURRENT ASSETS:  
    Cash and cash equivalents   $ 15,139   $ 16,816  
    Short-term investments    34,784    33,216  
    Accounts receivable, net    5,739    5,653  
    Inventories    2,735    2,051  
    Prepaid expenses and other current assets    1,200    988  


       Total current assets    59,597    58,724  
   Property and equipment, net    1,850    1,737  
   Intangible assets, net    12,510    13,338  
   Other assets    2,317    2,443  


    $ 76,274   $ 76,242  


LIABILITIES AND STOCKHOLDERS’ EQUITY
   CURRENT LIABILITIES:
    Accounts payable   $ 4,143   $ 4,323  
    Accrued expenses and other current liabilities    7,854    7,690  


       Total current liabilities    11,997    12,013  


   STOCKHOLDERS' EQUITY:
    Common stock    14    14  
    Additional paid-in capital    162,112    161,500  
    Accumulated other comprehensive loss    (38 )  (50 )
    Accumulated deficit    (97,811 )  (97,235 )


          Total stockholders' equity    64,277    64,229  


    $ 76,274   $ 76,242  


  

See accompanying notes to condensed consolidated financial statements.

-3-


Table of Contents

HIFN, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)
(unaudited)

Three Months Ended
December 31,

2004
2003
Net revenues            
   Processors   $ 11,179   $ 4,722  
   Software licenses and other    1,351    2,415  


       Total net revenues    12,530    7,137  


Costs and operating expenses:
   Cost of revenues - processors    3,817    1,350  
   Cost of revenues - software licenses and other    138    120  
   Research and development    5,414    4,689  
   Sales and marketing    1,919    1,688  
   General and administrative    1,177    993  
   Amortization of intangible assets    828    151  
   Purchased in-process research and development    -    3,337  


       Total costs and operating expenses    13,293    12,328  


Loss from operations    (763 )  (5,191 )
Interest and other income, net    189    102  


Loss before income taxes    (574 )  (5,089 )
Provision for income taxes    2    -  


Net loss   $ (576 ) $ (5,089 )


Net loss per share, basic and diluted   $ (0.04 ) $ (0.45 )


Weighted average shares outstanding, basic and diluted    13,968    11,390  


See accompanying notes to condensed consolidated financial statements.

-4-


Table of Contents

HIFN, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
(unaudited)

Three Months Ended
December 31,

2004
2003
Cash flows from operating activities:            
      Net loss   $ (576 ) $ (5,089 )
      Adjustments to reconcile net loss to
      net cash used in operating activities:
        Depreciation    221    346  
        Amortization of intangible assets    828    151  
        Amortization of deferred stock compensation    -    44  
        Purchased in-process research and development    -    3,337  
      Changes in assets and liabilities:  
        Accounts receivable    (86 )  713  
        Inventories    (684 )  (493 )
        Prepaid expenses and other current assets    (212 )  (770 )
        Other assets    126    191  
        Accounts payable    (1 )  (7 )
        Accrued expenses and other current liabilities    164    (1,046 )


          Net cash used in operating activities    (220 )  (2,623 )


Cash flows from investing activities:  
      Purchase of certain assets and intellectual property    -    (15,755 )
      Purchases of short-term investments, net    (1,556 )  (5,990 )
      Purchases of property and equipment    (334 )  (238 )


          Net cash used in investing activities    (1,890 )  (21,983 )


Cash flows from financing activities:
      Proceeds from issuance of common stock    612    1,223  
      Installment payments on acquired software licenses    (179 )  -  


          Net cash provided by financing activities    433    1,223  


Net decrease in cash and cash equivalents    (1,677 )  (23,383 )
Cash and cash equivalents at beginning of period    16,816    41,080  


Cash and cash equivalents at end of period   $ 15,139   $ 17,697  


See accompanying notes to condensed consolidated financial statements.

-5-


Table of Contents

HIFN, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Note 1 — Basis of Presentation

        The condensed consolidated financial statements of hi/fn, inc. (“Hifn” or the “Company”) include the accounts of the Company and its wholly-owned subsidiaries, Hifn Limited, Hifn Netherlands B.V. and Hifn International, and its wholly-owned subsidiary, Saian Microsystems, Inc. All significant intercompany accounts and transactions have been eliminated. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

        The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Financial Statements and notes thereto included in the Company’s Form 10-K for period ending September 30, 2004. In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments, consisting only of normal recurring adjustments, which the Company believes is necessary for a fair statement of the Company’s financial position as of December 31, 2004 and its results of operations for the three months ended December 31, 2004 and 2003, respectively. These condensed consolidated financial statements are not necessarily indicative of the results to be expected for the entire year.

        The Company anticipates that its existing cash, cash equivalents and short-term investments will fund any anticipated operating losses, purchases of capital equipment and provide adequate working capital for the next twelve months. The Company’s liquidity is affected by many factors including, among others, the extent to which the Company pursues additional capital expenditures, the level of the Company’s product development efforts, and other factors related to the uncertainties of the industry and global economies. Accordingly, there can be no assurance that events in the future will not require the Company to seek additional capital sooner or, if so required, that such capital will be available on terms acceptable to the Company.

        On February 6, 2004, the Company entered into a securities purchase agreement with certain investors for the private placement of 2.2 million shares of the Company’s Common Stock at a price of $15.00 per share for aggregate proceeds of $30.9 million, net of expenses of approximately $2.1 million. The shares were issued and paid for on February 6, 2004. The Company intends to apply the net proceeds for working capital and general corporate purposes, as well as for strategic purposes in connection with selected acquisitions that may be considered in the future to expand its product and service offerings. On April 9, 2004, the Registration Statement related to the private placement was declared effective by the Securities and Exchange Commission.

Note 2 — Stock Options

        The Company uses the intrinsic value method of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” in accounting for its employee stock options, and presents disclosure of pro forma information required under Statement of Financial Accounting Standards Board (“FASB”) Statement No. 123, “Accounting for Stock-Based Compensation” as amended by FASB Statement No. 148, “Accounting for Stock-Based Compensation — Transition and Disclosure — an amendment of FASB Statement No. 123.”

-6-


Table of Contents

        Had compensation expense for the Company’s stock-based compensation plans been determined based on the fair value method, the Company’s net loss and net loss per share would have been as follows:

Three Months Ended
December 31,

2004
2003
(in thousands,
except per share data)
Net loss:            
  As reported   $ (576 ) $ (5,089 )
    Add: stock-based employee compensation recorded
      in the Statement of Operations    -    44  
    Less: fair value of stock-based employee compensation    (1,386 )  (2,183 )


  Pro forma   $ (1,962 ) $ (7,228 )


Net loss per share:  
    Basic and diluted
      As reported   $ (0.04 ) $ (0.45 )
      Pro forma    (0.14 )  (0.63 )

        The fair value of each stock option is estimated on the date of grant using the Black-Scholes model with the following assumptions used for grants during the respective periods:

Three Months Ended
December 31,

2004
2003
Estimated option life      2.8 years  4.0 years
Risk-free interest rate    2.02%  2.81%
Expected volatility    58.5%  90.0%
Expected dividend yield    0.00%  0.00%
Weighted average estimated fair value   $ 3.66 $ 6.92

Note 3 — Net Loss Per Share

        Basic earnings per share is computed using the weighted average number of common shares outstanding for the period, without consideration for the dilutive impact of potential common shares that were outstanding during the period. Diluted earnings per share is computed using the weighted average number of common and common equivalent shares outstanding for the period. Common equivalent shares consist of incremental common shares issuable upon the exercise of stock options, using the treasury method, and are excluded from the calculation of diluted net loss per share if anti-dilutive. Outstanding options to purchase shares of common stock and their weighted shares equivalents excluded from the computation of diluted earnings because of their anti-dilutive impact were as follows:

Three Months Ended
December 31,

2004
2003
Outstanding options to purchase common stock      4,166,488    4,001,296  
Weighted equivalent shares    429,886    675,394  

-7-


Table of Contents

Note 4 — Detailed Balance Sheet

December 31,
2004

September 30,
2004

(in thousands)
Property and equipment:            
   Computer equipment   $ 6,584   $ 6,357  
   Furniture and fixtures    1,044    1,020  
   Leasehold improvements    979    937  
   Office equipment    799    758  


     9,406    9,072  
   Less: accumulated depreciation    (7,556 )  (7,335 )


    $ 1,850   $ 1,737  


Intangible assets:
   Developed and core technology   $ 17,460   $ 17,460  
   Workforce    413    413  
   Patents    600    600  


     18,473    18,473  
      Less: accumulated amortization    (6,992 )  (6,164 )


     11,481    12,309  
   Goodwill    1,029    1,029  


    $ 12,510   $ 13,338  


Accrued expenses and other current liabilities:  
  &n